President’s Letter | November 2020
From the Desk of Samantha Guild It’s hard to believe that we’re nearing the holiday season and the end of…
Blog - Melanoma360
11/12/2020
President’s Letter | November 2020
From the Desk of Samantha Guild It’s hard to believe that we’re nearing the holiday season and the end of…
|
11/12/2020
Survivor Spotlight: Stephanie Bowen, Stage IV Survivor
A Woman of Determination By Mara Klecker The second diagnosis came just days before Christmas 2010, almost exactly a decade…
|
11/12/2020
Survivor Spotlight: Tom Lauritzen, Stage III Survivor
On the Road Again…Soon By, Alicia Rowell Tom Lauritzen has lived his whole life in Pittsburgh, Pennsylvania, save for a…
|
11/12/2020
In Plain English—Neo-Adjuvant Therapy for Palpable/Resectable Stage III Melanoma
By Kim Margolin, M.D. In this chapter of “In Plain English,” we will describe the concept of neo-adjuvant therapy. Certain terms…
|
09/29/2020
Have You Checked Out Our New Website?
AIM announced the launch of our redesigned website last week. Have you had an opportunity to take a look? Every…
09/29/2020
President’s Letter |September 2020
From the Desk of Samantha Guild The fall is upon us, and here at AIM at Melanoma, we’re busy with…
|
09/29/2020
Joe Small: Stage III Survivor Spotlight
By, Alicia Rowell It was 2016—October, specifically—when Joe Small showed a little spot on his right forearm to his doctor…
|
09/29/2020
In Plain English: What is a “Triplet,” and Why Does it Matter in Melanoma?
By Kim Margolin, M.D. A “triplet” is the casual term to describe the combination of three drugs to treat cancer.…
|
06/03/2020
President’s Update June | 2020
June|2020 Greetings to the AIM at Melanoma community, Thank you for so many thoughtful acknowledgments and heartfelt tributes for my…
|
06/03/2020
AIM’s Steps Against Melanoma Walks Go Virtual
AIM’s Steps Against Melanoma walks have been a symbol of hope and support for our community for many years.…
Recent Posts
Oct. 17, 2024
In Plain English: Update on Melanoma Vaccines, 2024
Oct. 15, 2024
Options For Stage II Melanoma: Making the Decision that’s Right For You
Oct. 10, 2024
Coolibar’s Generous Donation to the AIM at Melanoma Foundation
Oct. 10, 2024
Fall 2024 Newsletter
Oct. 10, 2024